Cross-talk between dyslipidemia and renin–angiotensin system and the role of LOX-1 and MAPK in atherogenesis: Studies with the combined use of rosuvastatin and candesartan

This publication has 34 references indexed in Scilit:

• Angiotensin Receptor Blockade With Candesartan Attenuates Atherosclerosis, Plaque Disruption, and Macrophage Accumulation Within the Plaque in a Rabbit Model
  Circulation, 2004
• Interactions Between the Renin-Angiotensin System and Dyslipidemia
  Archives of internal medicine (1960), 2003
• Renin-Angiotensin System and Atherothrombotic Disease
  Archives of internal medicine (1960), 2003
• Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
  Journal of the American College of Cardiology, 2003
• Anti-thrombotic Effects of Atorvastatin-An Effect Unrelated to Lipid Lowering
  Journal of Cardiovascular Pharmacology and Therapeutics, 2002
• Statins Modulate Oxidized Low-Density Lipoprotein-Mediated Adhesion Molecule Expression in Human Coronary Artery Endothelial Cells: Role of LOX-1
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• The Effect of Statins on mRNA Levels of Genes Related to Inflammation, Coagulation, and Vascular Constriction in HUVEC.
  Journal of Atherosclerosis and Thrombosis, 2002
• Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation
  Cardiovascular Research, 2001
• Oxidized LDL Upregulates Angiotensin II Type 1 Receptor Expression in Cultured Human Coronary Artery Endothelial Cells
  Circulation, 2000
• Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts.
  Circulation, 1997